Article

Patient presents with unilateral blurred vision

A 50-year-old Haitian-born woman pre­sented to the Bascom Palmer Eye Institute with a complaint of suddenly decreased vision in her right eye over the previous 4 days. The patient denied other symptoms of pain, redness, photophobia, floaters, or photopsias.

The patient worked as a nursing assistant at an assisted living facility. She had been unable to work due to recent problems with vision and general weakness. She had noted a 40-pound weight loss over the previous 2 months. The patient denied a history of substance use but had been taking myriad herbal medications.

Examination

Case unfolding

Once the findings of hemorrhage were explained, the patient volunteered a past diagnosis of chronic myelogenous leukemia (CML), which was diagnosed 5 years previously at another hospital. At the time of diagnosis, the patient was treated with imatinib (Gleevec, Novartis) therapy, which was continued for 3 years. There was no history of radiation treatment. The patient had been unable to take imatinib for the past 2 years due to financial reasons and had been following with a "natural doctor," who had been treating her with herbal supplements, including vitamin C, a liquid preparation (Floradix, Flora), goldenseal, and black elderberry extract (Sambucol, Healthcare Brands).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.